Research-grade peptide compound designed to activate multiple hormone receptors—primarily GLP-1 (glucagon-like peptide-1), and often GIP and glucagon receptors—to study their effects on metabolic regulation, weight loss, and insulin sensitivity.
GLP-1 R 30MG - RETATRUTIDE
$300.00Price
GLP-1 receptor agonist: Enhances insulin secretion, slows gastric emptying, reduces appetite.
GIP receptor agonist (if included) : Supports insulin release and fat metabolism.
Glucagon receptor agonist (if included) : Boosts energy expenditure and fat breakdown.
The 30MG label refers to the total peptide content per vial, intended for in-vitro research only.